Novartis Bioventures Ltd Aileron Therapeutics Inc (ALRN) insider trading activity

Novartis Bioventures LTD is > 10% Shareholder of AILERON THERAPEUTICS INC. Currently has a direct ownership of 2.08 Million shares of ALRN, which is worth approximately $4.22 Million. The most recent transaction as insider was on Apr 01, 2019, when has been sold 20,610 shares (Common Stock) at a price of $1.9 per share, resulting in proceeds of $39,159. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.08M

0% 3M change

0% 12M change

Total Value Held $4.22 Million

Novartis Bioventures Ltd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2019	SELL Open market or private sale	$39,159 $1.9 p/Share	20,610 Reduced 0.98%	2,079,394 Common Stock
Mar 29 2019	SELL Open market or private sale	$197,099 $1.85 p/Share	106,540 Reduced 4.83%	2,100,004 Common Stock
Mar 15 2019	SELL Open market or private sale	$84,096 $1.92 p/Share	43,800 Reduced 1.95%	2,206,544 Common Stock
Mar 14 2019	SELL Open market or private sale	$25,944 $1.88 p/Share	13,800 Reduced 0.61%	2,250,344 Common Stock
Mar 13 2019	SELL Open market or private sale	$281,405 $2.12 p/Share	132,738 Reduced 5.54%	2,264,144 Common Stock
Aug 20 2018	SELL Open market or private sale	$46,892 $2.3 p/Share	20,388 Reduced 0.84%	2,396,882 Common Stock
Aug 17 2018	SELL Open market or private sale	$18,270 $2.1 p/Share	8,700 Reduced 0.36%	2,417,270 Common Stock
Aug 16 2018	SELL Open market or private sale	$18,497 $2.1 p/Share	8,808 Reduced 0.36%	2,425,970 Common Stock
Aug 15 2018	SELL Open market or private sale	$5,665 $2.15 p/Share	2,635 Reduced 0.11%	2,434,778 Common Stock
Aug 14 2018	SELL Open market or private sale	$7,458 $2.26 p/Share	3,300 Reduced 0.14%	2,437,413 Common Stock
Aug 13 2018	SELL Open market or private sale	$3,776 $2.36 p/Share	1,600 Reduced 0.07%	2,440,713 Common Stock
Aug 10 2018	SELL Open market or private sale	$13,701 $2.44 p/Share	5,615 Reduced 0.23%	2,442,313 Common Stock
Aug 09 2018	SELL Open market or private sale	$583 $2.48 p/Share	235 Reduced 0.01%	2,447,928 Common Stock
Aug 08 2018	SELL Open market or private sale	$2,780 $2.78 p/Share	1,000 Reduced 0.04%	2,448,163 Common Stock
Aug 07 2018	SELL Open market or private sale	$5,165 $2.97 p/Share	1,739 Reduced 0.07%	2,449,163 Common Stock
Aug 06 2018	SELL Open market or private sale	$8,885 $3.02 p/Share	2,942 Reduced 0.12%	2,450,902 Common Stock
Aug 02 2018	SELL Open market or private sale	$15,658 $3.33 p/Share	4,702 Reduced 0.19%	2,453,844 Common Stock
Aug 01 2018	SELL Open market or private sale	$26,343 $3.22 p/Share	8,181 Reduced 0.33%	2,458,546 Common Stock
Jul 31 2018	SELL Open market or private sale	$13,815 $3.07 p/Share	4,500 Reduced 0.18%	2,466,727 Common Stock
Jul 30 2018	SELL Open market or private sale	$6,540 $3.27 p/Share	2,000 Reduced 0.08%	2,471,227 Common Stock
Jul 27 2018	SELL Open market or private sale	$21,828 $3.38 p/Share	6,458 Reduced 0.26%	2,473,227 Common Stock
Jul 26 2018	SELL Open market or private sale	$28,811 $3.63 p/Share	7,937 Reduced 0.32%	2,479,685 Common Stock
Jul 25 2018	SELL Open market or private sale	$47,846 $3.84 p/Share	12,460 Reduced 0.5%	2,487,622 Common Stock
Jul 24 2018	SELL Open market or private sale	$2,877 $4.11 p/Share	700 Reduced 0.03%	2,500,082 Common Stock
Jul 23 2018	SELL Open market or private sale	$130,050 $4.25 p/Share	30,600 Reduced 1.21%	2,500,782 Common Stock

Also insider at

BCYC

BICYCLE THERAPEUTICS plc Healthcare

> 10% Shareholder

ALT

Altimmune, Inc. Healthcare

> 10% Shareholder

AADI

Aadi Bioscience, Inc. Healthcare

> 10% Shareholder

AKUS

Akouos, Inc. Healthcare

ELDN

Eledon Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

GRTX

Galera Therapeutics, Inc. Healthcare

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

YMTX

YUMANITY THERAPEUTICS, INC. Healthcare

> 10% Shareholder

ATRX

Adhera Therapeutics, Inc. Healthcare

> 10% Shareholder

RARX

Ra Pharmaceuticals, Inc.

> 10% Shareholder

NBL